SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001520138-14-000311
Filing Date
2014-11-13
Accepted
2014-11-13 12:42:26
Documents
9
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q nnab-20140930_10q.htm 10-Q 186156
2 EXHIBIT 31.1 nnab-20140930_10qex31z1.htm EX-31.1 17600
3 EXHIBIT 32.1 nnab-20140930_10qex32z1.htm EX-32.1 5941
  Complete submission text file 0001520138-14-000311.txt   1266496

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE nnab-20140930.xml EX-101.INS 111032
5 XBRL SCHEMA FILE nnab-20140930.xsd EX-101.SCH 13421
6 XBRL PRESENTATION FILE nnab-20140930_pre.xml EX-101.PRE 71210
7 XBRL LABEL FILE nnab-20140930_lab.xml EX-101.LAB 100539
8 XBRL CALCULATION FILE nnab-20140930_cal.xml EX-101.CAL 17165
9 XBRL DEFINITION FILE nnab-20140930_def.xml EX-101.DEF 15172
Mailing Address 100 CUMMINGS CENTER, SUITE 247-C BEVERLY MA 01915
Business Address 100 CUMMINGS CENTER, SUITE 247-C BEVERLY MA 01915 3055154118
NANOANTIBIOTICS, INC. (Filer) CIK: 0001580149 (see all company filings)

IRS No.: 462510769 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-55292 | Film No.: 141217281
SIC: 2834 Pharmaceutical Preparations